Legal & General Group Plc - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 60 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$14,000
-12.5%
1,961
-4.6%
0.00%
Q4 2020$16,000
+14.3%
2,056
+36.4%
0.00%
Q3 2020$14,000
-22.2%
1,507
-29.2%
0.00%
Q2 2020$18,000
+125.0%
2,130
+30.6%
0.00%
Q1 2020$8,000
-33.3%
1,6310.0%0.00%
Q4 2019$12,000
-14.3%
1,631
+29.5%
0.00%
Q3 2019$14,000
-12.5%
1,2590.0%0.00%
Q2 2019$16,000
+33.3%
1,2590.0%0.00%
Q1 2019$12,000
-7.7%
1,2590.0%0.00%
Q4 2018$13,0001,2590.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Orbimed Advisors 8,466,783$5,758,0000.09%
HARBOR CAPITAL ADVISORS, INC. 226,731$154,0000.07%
Sio Capital Management, LLC 182,630$124,0000.04%
Virtu Financial LLC 71,475$49,0000.00%
Independence Bank of Kentucky 10,200$7,0000.00%
SANDERS MORRIS HARRIS LLC 15,000$10,0000.00%
Endurance Wealth Management, Inc. 1,500$12,0000.00%
Baker Brothers Advisors 451,478$307,0000.00%
Texas Yale Capital Corp. 20,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,900$54,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders